March 2011 – Page 3 – Policy & Medicine

FDA Guidance for Industry on Medication Guides

University Policy: Duke and UNC Consider Revising Policies on Collaboration with Commercial Interests

University Policies Make Them Easier or Harder?

Pharmaceutical Coupons A Health Choice

Maryland “Gift Ban”: HB 818 Manufacturers of Prescribed Products – Payments to Health Care Professionals – Committee Hearing

HHS-OIG: CMS-FDA Drug Registration and Listing Systems In Need of Update

ABMS MOC CME White Paper: SACME and CMSS Responses

Alliance for CME Social Media Best Practice Guidelines

AMA CPPD Report : Change to Physician Recognition Award, Physician Re-Entry

Supreme Court Rules in Favor of Protecting Vaccine Makers from State Lawsuits